Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Details for Australian Patent Application No. 2004270211 (hide)

Owner Celgene Corporation

Inventors Chen, Roger Shen-Chu; Muller, George W.; Saindane, Manohar T.; Jaworsky, Markian S.; Cameron, Louise M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004270211

PCT Pub. Number WO2005/023192

Priority 60/499,723 04.09.03 US

Filing date 3 September 2004

Wipo publication date 17 March 2005

Acceptance publication date 23 October 2008

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023192 Priority application(s): WO2005/023192

23 October 2008 Application Accepted

  Published as AU-B-2004270211

19 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270220-Method for non-invasive prenatal diagnosis

2004270208-Dual blade laryngoscope with esophageal obturator